Clinical Trial Update: Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating Megestrol acetate or levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia or endometrial cancer was w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia
• Endometrial Cancer

Drugs mentioned

• Levonorgestrel-Releasing Intrauterine System (levonorgestrel-releasing intrauterine system)
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: University of Southern California | Conditions: Atypical Endometrial Hyperplasia, Endometrial Adenocarcinoma | Phase 2 | Status: WITHDRAWN